XLRN
$106.18
Acceleron Pharma
$.88
.84%
XLRN
Earnings Whisper ®
N/A
2nd Quarter June 2020
Consensus:  ($0.55)
Revenue:  $19.84 Mil
Thursday
Aug 6
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when XLRN reports earnings?
Beat
Meet
Miss

Where is XLRN's stock price going from here?
Up
Flat
Down
Stock chart of XLRN
Analysts
Summary of analysts' recommendations for XLRN
Score
Grade
Pivots
Resistance
$110.30
$108.40
$107.29

$105.39

Support
$104.28
$102.38
$101.27
Tweet
Growth
Description
Acceleron Pharma Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. Acceleron Pharma Inc. is based in Cambridge, Massachusetts.
Peers
BiogenAmgenGilead SciencesNeurocrine BiosciencesSeattle GeneticsBluebird BioQiagen N.V.NovavaxRepligenBio-Techne